ABT: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/ca1cd919-b40d-4594-ba2a-582437ad63c3/","filing_uuid":"ca1cd919-b40d-4594-ba2a-582437ad63c3","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/ca1cd919-b40d-4594-ba2a-582437ad63c3/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Darren Willcox","dt_posted":"2026-10-19T23:44:39-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Avenue, NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400605842,"url":"https://lda.gov/api/v1/registrants/400605842/","house_registrant_id":null,"name":"W STRATEGIES, LLC","description":"Government Affairs Consulting Firm.","address_1":"1455 Pennsylvania Avenue, NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DARREN WILLCOX","contact_telephone":"+1 202-494-6268","dt_updated":"2026-07-30T12:17:37.753365-04:00"},"client":{"id":193490,"url":"https://lda.gov/api/v1/clients/193490/","client_id":63,"name":"ABBOTT LABORATORIES","general_description":"A pharmaceuticals health care company.","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to infant formula access. Issues related to DMEPOS reimbursement by CMS. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51473,"prefix":null,"prefix_display":null,"first_name":"DARREN","nickname":null,"middle_name":null,"last_name":"WILLCOX","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}